|
Cemcat International Rounds (ed. 2026)
|
23/02/2026 - 30/11/2026
|
Spain
|
Barcelona
|
Website
|
Neurology
|
Fundació Privada Cemcat
|
| Module title |
Module date |
Website of the module |
Amount of ECMEC® credits |
| Remyelination in MS: what the data really tell us |
2026-02-23 |
Website |
1.0 European CME credits (ECMEC®) |
| All new lesions in MS should have CVS? |
2026-03-30 |
Website |
1.0 European CME credits (ECMEC®) |
| Treatment of Progressive Disease |
2026-05-04 |
Website |
1.0 European CME credits (ECMEC®) |
| Concordance and biology of chronic active lesions, PRL and SELs |
2026-06-01 |
Website |
1.0 European CME credits (ECMEC®) |
| MS Differential Diagnosis |
2026-06-29 |
Website |
1.0 European CME credits (ECMEC®) |
| Overlapping forms of MS, NMOSD and MOGAD |
2026-07-27 |
Website |
1.0 European CME credits (ECMEC®) |
| Cancer and MS |
2026-09-28 |
Website |
1.0 European CME credits (ECMEC®) |
| Future treatment strategies against Epstein-Barr virus in MS |
2026-11-09 |
Website |
1.0 European CME credits (ECMEC®) |
| Immune checkpoint inhibitor-related encephalitis. Phenotypes, outcomes and biomarkers |
2026-11-30 |
Website |
1.0 European CME credits (ECMEC®) |
|
